Chevron's Kazakhstan oil field projects have started to make a positive contribution in terms of production volume. Read why ...

President Trump said “buy.” Investors saluted, clicked, and positioned for a trade breakthrough. On Monday, they got one.

Compass Therapeutics' tovecimig shows promise in biliary cancer, boasting a 17.1% response rate. Despite high risks, I ...

Baby Boomers' spending power shapes sectors like retail and healthcare. Costco's (COST) consistent dividend growth and share ...

Golar LNG secures long-term FLNG contracts, boosting EBITDA and derisking its outlook. Read why GLNG stock is a Buy.

The Franklin Total Return Fund's security selection in IG corporate bonds contributed to relative performance. Click here to ...

PowerFleet faces challenges with weak cash flow and high leverage, despite growth potential from acquisitions. Read more on ...

CA ETF is a top choice for Canadian market exposure, strong dividends, and diversification. Read here for an in-depth ...

The ClearBridge Small Cap Fund outperformed (without sales charges) its Russell 2000 Index benchmark during Q1 2025. Click ...

The ClearBridge Mid Cap Fund underperformed its benchmark for the first quarter of 2025. Click here to read the full ...

Not all investors are looking to tame volatility. Some short-term traders prefer the opposite for amplified exposure.

The trade agreement between India and the United Kingdom announced on May 6, finalized after three years of negotiations, is ...